What question did this study set out to answer?

This study aims to investigate the expression of angiotensin II type 1 receptor in pancreatic cancer and its role in tumor growth.

April 25, 2001FEBS LettersOpen Access

Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist

View Full Paper

Ask AI

Bookmark

Why the study?

Does a selective AT1 antagonist inhibit the growth of human pancreatic cancer cells?

Population

Human pancreatic cancer tissues and cell lines

Comparison

Selective angiotensin II type 1 receptor… vs Untreated/control

Design

Preclinical

Authors

YFYoshifumi FujimotoHiroshima General Hospital TSTamito SasakiHiroshima Prefectural Hospital ATAkira TsuchidaUniversity of Fukui

Discussion

Member takes

Implication

AT1 blockade merits further preclinical study in pancreatic cancer; leaves open clinical translation pending human trials.

Key Points

This study aims to investigate the expression of angiotensin II type 1 receptor in pancreatic cancer and its role in tumor growth.
Analyzed AT1 mRNA and protein levels in pancreatic cancer tissues and cell lines.
Performed binding assays to test specific binding of angiotensin II in cancer cells.
Evaluated the effects of a selective AT1 antagonist on cancer cell growth in a dose-dependent manner.
Observed that AT1 mRNA and protein are expressed in pancreatic cancer tissues.
Demonstrated that binding of angiotensin II to pancreatic cancer cells is specific and can be blocked by AT1 antagonist.
Showed significant cancer cell growth suppression with antagonist treatment in a dose-dependent manner.

Structured PICO

Does a selective AT1 antagonist inhibit the growth of human pancreatic cancer cells?

Population

Human pancreatic cancer tissues and cell lines

Intervention

Selective angiotensin II type 1 receptor (AT1) antagonist

Comparator

Untreated/control

Outcome

AT1 receptor expression and cancer cell growthsurrogate

AT1 receptors are expressed in human pancreatic cancer and their blockade inhibits cancer cell growth, suggesting a potential therapeutic strategy.

Cite This Study

Fujimoto et al. (2001) studied this question.

synapsesocial.com/papers/6a0a596feda9b9caed96aed3 https://doi.org/10.1016/s0014-5793(01)02377-8

View Full Paper

Ask AI

Bookmark

Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider